Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
48.35
-0.95 (-1.93%)
Apr 2, 2025, 1:30 PM CST

Medigen Vaccine Biologics Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
15,89411,85123,03522,78563,65321,743
Upgrade
Market Cap Growth
-48.55%-48.55%1.10%-64.20%192.75%388.97%
Upgrade
Enterprise Value
14,31810,38221,27120,54062,66022,145
Upgrade
Last Close Price
48.3536.0570.1069.50200.9169.21
Upgrade
PE Ratio
----45.14-
Upgrade
PS Ratio
26.2419.5759.1262.4219.401889.56
Upgrade
PB Ratio
4.133.085.994.5313.616.92
Upgrade
P/TBV Ratio
3.103.106.054.5713.777.06
Upgrade
P/FCF Ratio
2461.941835.64--142.64-
Upgrade
P/OCF Ratio
290.80290.80--109.77-
Upgrade
EV/Sales Ratio
23.6417.1454.5956.2719.101924.50
Upgrade
EV/EBITDA Ratio
---58.45-
Upgrade
EV/EBIT Ratio
---65.02-
Upgrade
EV/FCF Ratio
2217.731608.05--140.41-
Upgrade
Debt / Equity Ratio
0.090.090.510.390.040.06
Upgrade
Debt / EBITDA Ratio
----0.17-
Upgrade
Debt / FCF Ratio
52.5052.50--0.42-
Upgrade
Asset Turnover
0.120.120.060.060.750.00
Upgrade
Inventory Turnover
0.500.500.250.762.840.09
Upgrade
Quick Ratio
9.549.541.9912.486.5411.58
Upgrade
Current Ratio
11.9411.942.2115.388.4812.48
Upgrade
Return on Equity (ROE)
-2.09%-2.09%-26.14%-30.39%36.08%-29.91%
Upgrade
Return on Assets (ROA)
-1.74%-1.74%-11.29%-15.18%13.71%-16.55%
Upgrade
Return on Capital (ROIC)
-1.82%-1.82%-11.85%-16.21%14.71%-17.38%
Upgrade
Return on Capital Employed (ROCE)
----19.80%-
Upgrade
Earnings Yield
-0.51%-0.68%-5.04%-6.47%2.22%-3.10%
Upgrade
FCF Yield
0.04%0.05%-2.26%-5.94%0.70%-3.17%
Upgrade
Buyback Yield / Dilution
-0.10%-0.10%-1.50%-0.73%-15.82%-20.08%
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.